Stempoint Capital’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78M | Sell |
601,781
-1,977,079
| -77% | -$22.3M | 2.18% | 17 |
|
|
2025
Q1 | $26M | Sell |
2,578,860
-133,918
| -5% | -$1.35M | 8.29% | 1 |
|
|
2024
Q4 | $32.1M | Sell |
2,712,778
-57,041
| -2% | -$675K | 8.01% | 2 |
|
|
2024
Q3 | $32M | Buy |
2,769,819
+57,078
| +2% | +$659K | 9.57% | 2 |
|
|
2024
Q2 | $28.7M | Sell |
2,712,741
-841,103
| -24% | -$8.89M | 8.43% | 2 |
|
|
2024
Q1 | $37.5M | Buy |
3,553,844
+1,384,728
| +64% | +$14.6M | 9.9% | 1 |
|
|
2023
Q4 | $24.4M | Buy |
+2,169,116
| New | +$24.4M | 6.5% | 1 |
|